US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist
  • 8.760
  • +0.010+0.11%
Close Nov 8 16:00 ET
  • 8.900
  • +0.140+1.60%
Post 16:08 ET
171.10MMarket Cap-5938P/E (TTM)

Actuate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
--351.71K
--2.07M
-85.53%2.96M
--20.45M
-Cash and cash equivalents
--351.71K
--2.07M
-85.53%2.96M
--20.45M
Other current assets
--197.98K
--119.77K
9.37%36.91K
--33.75K
Total current assets
--549.69K
--2.19M
-85.38%3M
--20.48M
Non current assets
Non current deferred assets
--1.18M
--510.5K
----
----
Total non current assets
--1.18M
--510.5K
--0
--0
Total assets
--1.73M
--2.7M
-85.38%3M
--20.48M
Liabilities
Current liabilities
Payables
--5.89M
--3.96M
60.59%3.42M
--2.13M
-accounts payable
--5.89M
--3.96M
60.59%3.42M
--2.13M
Current accrued expenses
--7M
--5.5M
54.71%3.22M
--2.08M
Current debt and capital lease obligation
--6.9M
--5M
----
----
-Current debt
--6.9M
--5M
----
----
Current liabilities
--20.07M
--14.73M
59.28%6.92M
--4.34M
Non current liabilities
Non current accrued expenses
--70.1K
--135.12K
50.51%130.04K
--86.4K
Derivative product liabilities
--1.26M
--1.02M
21.33%988.05K
--814.36K
Preferred securities outside stock equity
--94.18M
--94.18M
4.48%94.18M
--90.14M
Total non current liabilities
--95.91M
--95.74M
4.66%95.7M
--91.44M
Total liabilities
--115.99M
--110.47M
7.13%102.62M
--95.79M
Shareholders'equity
Share capital
--2
--2
0.00%2
--2
-common stock
--2
--2
0.00%2
--2
Retained earnings
---119.96M
---113.39M
-30.80%-105.09M
---80.35M
Paid-in capital
--5.71M
--5.62M
8.40%5.47M
--5.04M
Total stockholders'equity
---114.26M
---107.77M
-32.30%-99.63M
---75.31M
Total equity
---114.26M
---107.77M
-32.30%-99.63M
---75.31M
Currency Unit
USD
USD
USD
USD
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments --351.71K--2.07M-85.53%2.96M--20.45M
-Cash and cash equivalents --351.71K--2.07M-85.53%2.96M--20.45M
Other current assets --197.98K--119.77K9.37%36.91K--33.75K
Total current assets --549.69K--2.19M-85.38%3M--20.48M
Non current assets
Non current deferred assets --1.18M--510.5K--------
Total non current assets --1.18M--510.5K--0--0
Total assets --1.73M--2.7M-85.38%3M--20.48M
Liabilities
Current liabilities
Payables --5.89M--3.96M60.59%3.42M--2.13M
-accounts payable --5.89M--3.96M60.59%3.42M--2.13M
Current accrued expenses --7M--5.5M54.71%3.22M--2.08M
Current debt and capital lease obligation --6.9M--5M--------
-Current debt --6.9M--5M--------
Current liabilities --20.07M--14.73M59.28%6.92M--4.34M
Non current liabilities
Non current accrued expenses --70.1K--135.12K50.51%130.04K--86.4K
Derivative product liabilities --1.26M--1.02M21.33%988.05K--814.36K
Preferred securities outside stock equity --94.18M--94.18M4.48%94.18M--90.14M
Total non current liabilities --95.91M--95.74M4.66%95.7M--91.44M
Total liabilities --115.99M--110.47M7.13%102.62M--95.79M
Shareholders'equity
Share capital --2--20.00%2--2
-common stock --2--20.00%2--2
Retained earnings ---119.96M---113.39M-30.80%-105.09M---80.35M
Paid-in capital --5.71M--5.62M8.40%5.47M--5.04M
Total stockholders'equity ---114.26M---107.77M-32.30%-99.63M---75.31M
Total equity ---114.26M---107.77M-32.30%-99.63M---75.31M
Currency Unit USDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Recent IPOs
Recent IPOs
Intraday+2.26%